Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13045
Title: Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
Austin Authors: Burrell, Louise M ;Phillips, P A;Risvanis, John;Aldred, K L;Hutchins, A M;Johnston, Colin I
Affiliation: University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 1-Nov-1995
Publication information: Hypertension; 26(5): 828-34
Abstract: Abnormalities of the vasopressin system are found in genetic hypertension. This study compares the delayed effects of a brief period of vasopressin V1A receptor blockade and angiotensin-converting enzyme inhibition in young female and male spontaneously hypertensive rats (SHR) on the development of hypertension in adult life. In a separate study, the role of vasopressin in the maintenance of blood pressure in adult SHR was assessed. Young SHR received either the nonpeptide vasopressin V1A receptor antagonist OPC-21268, the angiotensin-converting enzyme inhibitor ramipril, or vehicle from 6 to 10 weeks of age. During the treatment period, OPC-21268 and ramipril reduced systolic blood pressure compared with control SHR (P < .001). Blood pressure in male SHR 7 weeks after treatment withdrawal was 178 +/- 1 mm Hg in ramipril-treated, 184 +/- 1 mm Hg in OPC-21268-treated, and 200 +/- 2 mm Hg in control SHR (P < .001). Similar results were seen in female SHR, although both OPC-21268 and ramipril were less effective antihypertensive agents in female compared with male SHR. The sustained attenuation in blood pressure was not associated with significant cardiovascular structural changes (left ventricular-to-body weight ratio, renal weight-to-body weight ratio, mesenteric resistance artery media-to-lumen ratio). Results of vasopressin V1A receptor binding kinetics and plasma renin or aldosterone concentrations did not suggest a lasting effect of OPC-21268 on the vasopressin system or of ramipril on the renin-angiotensin system following treatment withdrawal.(ABSTRACT TRUNCATED AT 250 WORDS)
Gov't Doc #: 7591025
URI: http://ahro.austin.org.au/austinjspui/handle/1/13045
URL: https://pubmed.ncbi.nlm.nih.gov/7591025
Type: Journal Article
Subjects: Aging
Angiotensin-Converting Enzyme Inhibitors.therapeutic use
Animals
Antidiuretic Hormone Receptor Antagonists
Blood Pressure
Body Weight
Female
Hypertension.genetics.physiopathology.prevention & control
Male
Piperidines.therapeutic use
Quinolones.therapeutic use
Ramipril.therapeutic use
Rats
Rats, Inbred SHR
Appears in Collections:Journal articles

Show full item record

Page view(s)

10
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.